These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Characterization of pSer129-αSyn Pathology and Neurofilament Light-Chain Release across In Vivo, Ex Vivo, and In Vitro Models of Pre-Formed-Fibril-Induced αSyn Aggregation. Hansen ML; Ambjørn M; Harndahl MN; Benned-Jensen T; Fog K; Bjerregaard-Andersen K; Sotty F Cells; 2024 Jan; 13(3):. PubMed ID: 38334646 [TBL] [Abstract][Full Text] [Related]
4. Nuclear and neuritic distribution of serine-129 phosphorylated alpha-synuclein in transgenic mice. Schell H; Hasegawa T; Neumann M; Kahle PJ Neuroscience; 2009 Jun; 160(4):796-804. PubMed ID: 19272424 [TBL] [Abstract][Full Text] [Related]
5. Pathogenic alpha-synuclein aggregates preferentially bind to mitochondria and affect cellular respiration. Wang X; Becker K; Levine N; Zhang M; Lieberman AP; Moore DJ; Ma J Acta Neuropathol Commun; 2019 Mar; 7(1):41. PubMed ID: 30871620 [TBL] [Abstract][Full Text] [Related]
6. 14-3-3 mitigates alpha-synuclein aggregation and toxicity in the in vivo preformed fibril model. Underwood R; Gannon M; Pathak A; Kapa N; Chandra S; Klop A; Yacoubian TA Acta Neuropathol Commun; 2021 Jan; 9(1):13. PubMed ID: 33413679 [TBL] [Abstract][Full Text] [Related]
7. Phosphorylation and oligomerization of α-synuclein associated with GSK-3β activation in the rTg4510 mouse model of tauopathy. Takaichi Y; Chambers JK; Inoue H; Ano Y; Takashima A; Nakayama H; Uchida K Acta Neuropathol Commun; 2020 Jun; 8(1):86. PubMed ID: 32560668 [TBL] [Abstract][Full Text] [Related]
8. Comparing alpha-synuclein-interactomes between multiple systems atrophy and Parkinson's disease reveals unique and shared pathological features. Choi SG; Tittle T; Barot R; Betts D; Gallagher J; Kordower JH; Chu Y; Killinger BA bioRxiv; 2024 Sep; ():. PubMed ID: 39345456 [TBL] [Abstract][Full Text] [Related]
9. Disease-, region- and cell type specific diversity of α-synuclein carboxy terminal truncations in synucleinopathies. Hass EW; Sorrentino ZA; Xia Y; Lloyd GM; Trojanowski JQ; Prokop S; Giasson BI Acta Neuropathol Commun; 2021 Aug; 9(1):146. PubMed ID: 34454615 [TBL] [Abstract][Full Text] [Related]
10. Preserved proteinase K-resistant core after amplification of alpha-synuclein aggregates: Implication to disease-related structural study. Yoshinaga S; Yamanaka T; Miyazaki H; Okuzumi A; Hiyama A; Murayama S; Nukina N Biochem Biophys Res Commun; 2020 Feb; 522(3):655-661. PubMed ID: 31785806 [TBL] [Abstract][Full Text] [Related]
11. A novel mouse model for investigating α-synuclein aggregates in oligodendrocytes: implications for the glial cytoplasmic inclusions in multiple system atrophy. Ishimoto T; Oono M; Kaji S; Ayaki T; Nishida K; Funakawa I; Maki T; Matsuzawa SI; Takahashi R; Yamakado H Mol Brain; 2024 May; 17(1):28. PubMed ID: 38790036 [TBL] [Abstract][Full Text] [Related]
15. Deposition of Phosphorylated α-Synuclein in the rTg4510 Mouse Model of Tauopathy. Takaichi Y; Ano Y; Chambers JK; Uchida K; Takashima A; Nakayama H J Neuropathol Exp Neurol; 2018 Oct; 77(10):920-928. PubMed ID: 30107539 [TBL] [Abstract][Full Text] [Related]
16. Carboxy-terminal truncation and phosphorylation of α-synuclein elongates survival in a prion-like seeding mouse model of synucleinopathy. Sorrentino ZA; Hass E; Vijayaraghavan N; Gorion KM; Riffe CJ; Dhillon JS; Giasson BI Neurosci Lett; 2020 Jul; 732():135017. PubMed ID: 32371157 [TBL] [Abstract][Full Text] [Related]
17. 14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein. Wang B; Underwood R; Kamath A; Britain C; McFerrin MB; McLean PJ; Volpicelli-Daley LA; Whitaker RH; Placzek WJ; Becker K; Ma J; Yacoubian TA J Neurosci; 2018 Sep; 38(38):8211-8232. PubMed ID: 30093536 [TBL] [Abstract][Full Text] [Related]
18. α-Synuclein Strains and Their Relevance to Parkinson's Disease, Multiple System Atrophy, and Dementia with Lewy Bodies. Graves NJ; Gambin Y; Sierecki E Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569510 [TBL] [Abstract][Full Text] [Related]
19. Physiological C-terminal truncation of α-synuclein potentiates the prion-like formation of pathological inclusions. Sorrentino ZA; Vijayaraghavan N; Gorion KM; Riffe CJ; Strang KH; Caldwell J; Giasson BI J Biol Chem; 2018 Dec; 293(49):18914-18932. PubMed ID: 30327435 [TBL] [Abstract][Full Text] [Related]
20. Neuronal activity modulates alpha-synuclein aggregation and spreading in organotypic brain slice cultures and in vivo. Wu Q; Shaikh MA; Meymand ES; Zhang B; Luk KC; Trojanowski JQ; Lee VM Acta Neuropathol; 2020 Dec; 140(6):831-849. PubMed ID: 33021680 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]